These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 31770382)
1. Long-term mortality in mothers of infants with neonatal abstinence syndrome: A population-based parallel-cohort study in England and Ontario, Canada. Guttmann A; Blackburn R; Amartey A; Zhou L; Wijlaars L; Saunders N; Harron K; Chiu M; Gilbert R PLoS Med; 2019 Nov; 16(11):e1002974. PubMed ID: 31770382 [TBL] [Abstract][Full Text] [Related]
3. Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis. Ko JY; Yoon J; Tong VT; Haight SC; Patel R; Rockhill KM; Luck J; Shapiro-Mendoza C Drug Alcohol Depend; 2021 Jun; 223():108704. PubMed ID: 33894458 [TBL] [Abstract][Full Text] [Related]
4. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality. Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175 [TBL] [Abstract][Full Text] [Related]
5. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida. Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694 [TBL] [Abstract][Full Text] [Related]
6. Maternal opioid use disorder and neonatal abstinence syndrome in northwest Ontario: a 7-year retrospective analysis. Dooley J; Ryan G; Gerber Finn L; Bollinger M; Matsumoto CL; Hopman WM; Kelly L Can J Rural Med; 2018; 23(2):39-44. PubMed ID: 29547380 [TBL] [Abstract][Full Text] [Related]
7. Identification of Prenatal Opioid Exposure Within Health Administrative Databases. Camden A; Ray JG; To T; Gomes T; Bai L; Guttmann A Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33376211 [TBL] [Abstract][Full Text] [Related]
8. Narcotic-exposed neonates in a First Nations population in northwestern Ontario: incidence and implications. Kelly L; Dooley J; Cromarty H; Minty B; Morgan A; Madden S; Hopman W Can Fam Physician; 2011 Nov; 57(11):e441-7. PubMed ID: 22084474 [TBL] [Abstract][Full Text] [Related]
9. Infants Born to Opioid-Dependent Women in Ontario, 2002-2014. Brogly SB; Turner S; Lajkosz K; Davies G; Newman A; Johnson A; Dow K J Obstet Gynaecol Can; 2017 Mar; 39(3):157-165. PubMed ID: 28343557 [TBL] [Abstract][Full Text] [Related]
10. Neonatal Abstinence Syndrome (NAS) in Southwestern Border States: Examining Trends, Population Correlates, and Implications for Policy. Hussaini KS; Garcia Saavedra LF Matern Child Health J; 2018 Sep; 22(9):1352-1359. PubMed ID: 29572587 [TBL] [Abstract][Full Text] [Related]
11. Demographics, Birth Parameters, and Social Determinants of Health Among Opioid-Exposed Mother-Infant Dyads Affected by Neonatal Abstinence Syndrome in Pennsylvania, 2018-2019. Decker CM; Mahar M; Howells CL; Ma ZQ; Goetz CT; Watkins SM Matern Child Health J; 2023 Dec; 27(Suppl 1):34-43. PubMed ID: 37243807 [TBL] [Abstract][Full Text] [Related]
12. Are infants exposed to methadone in utero at an increased risk for mortality? Kelly LE; Rieder MJ; Bridgman-Acker K; Lauwers A; Madadi P; Koren G J Popul Ther Clin Pharmacol; 2012; 19(2):e160-5. PubMed ID: 22580362 [TBL] [Abstract][Full Text] [Related]
13. Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure. Faherty LJ; Matone M; Passarella M; Lorch S Matern Child Health J; 2018 Jun; 22(6):841-848. PubMed ID: 29417369 [TBL] [Abstract][Full Text] [Related]
14. One-Year Postpartum Mental Health Outcomes of Mothers of Infants with Neonatal Abstinence Syndrome. Corr TE; Schaefer EW; Hollenbeak CS; Leslie DL Matern Child Health J; 2020 Mar; 24(3):283-290. PubMed ID: 31925632 [TBL] [Abstract][Full Text] [Related]
15. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT BMJ; 2015 May; 350():h2102. PubMed ID: 25975601 [TBL] [Abstract][Full Text] [Related]
16. A longitudinal analysis of temporal and spatial incidence of neonatal abstinence syndrome in Ontario: 2003-2016. Dawson E; Lew J; Mauer-Vakil D; Van Dijk A; Belanger P; Moore KM J Opioid Manag; 2019; 15(3):205-212. PubMed ID: 31343722 [TBL] [Abstract][Full Text] [Related]
18. The relationship between gestational age and the severity of neonatal abstinence syndrome. Gibson KS; Stark S; Kumar D; Bailit JL Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650 [TBL] [Abstract][Full Text] [Related]
19. Neonatal Abstinence Syndrome: Trend and Expenditure in Louisiana Medicaid, 2003-2013. Okoroh EM; Gee RE; Jiang B; McNeil MB; Hardy-Decuir BA; Zapata AL Matern Child Health J; 2017 Jul; 21(7):1479-1487. PubMed ID: 28168591 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of birth defects among infants with neonatal abstinence syndrome in Illinois, 2015-2016. Fornoff J; Sandidge T Birth Defects Res; 2021 Jan; 113(2):134-143. PubMed ID: 32896979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]